U.S. FDA Approves PADCEV® plus Keytruda® for Certain Patients with Bladder Cancer
On Nov. 21, 2025, Pfizer and Astellas Pharma announced that the U.S. Food and Drug Administration (FDA) has…
Biotechnology | FDA | Oncology | Therapeutics
FDA approves first cancer drug based on Broad Institute science
On Nov. 20, 2025, the US Food and Drug Administration (FDA) has approved the first cancer drug based…
Biotechnology | Cardiology | Clinical Research | CRISPR | Disease | FDA | Genomics | HIV | Infectious Disease | Influenza | Nanotechnology | Neurology | NIH | Oncology | Organ Transplant | Rare Disease | Stem Cell | Therapeutics | U.S. Congress | Vaccine | Women's Health
Halted NIH Clinical Trials List Reveals Slashed Treatments for Cancer, COVID and Minority Health
On Nov. 20, 2025, the National Institutes of Health (NIH) has canceled funding for at least 383 clinical…
CPRIT approves $154 million in new cancer research and prevention awards, surpasses $4 billion total
On Nov. 19, 2025, the governing board of the Cancer Prevention and Research Institute of Texas (CPRIT) approved…
Novartis announces plans to build flagship manufacturing hub in North Carolina
On Nov. 19, 2025, Novartis, a leading global innovative medicines company, announced plans to expand its operations in…
Johnson & Johnson to acquire Halda Therapeutics for $3.05 billion, revolutionize treatment of cancer
On Nov. 17, 2025, Johnson & Johnson announced that it has entered into a definitive agreement to acquire…
Artificial Intelligence | Biotechnology | Energy | Environmental | Forestry | Genomics | Infectious Disease | Nanotechnology | Neurology | Oncology | Pharmaceutical | Therapeutics | Vaccine
China’s new scientist visa is a ‘serious bid’ for the world’s top talent
On Nov. 11, 2025, China introduced a visa that will allow young foreign researchers in science, technology, engineering…
Lilly announces $1.2 billion investment in Puerto Rico facility to boost oral medicine manufacturing capacity in the U.S.
On Oct. 29, 2025, Eli Lilly announced a planned investment of more than $1.2 billion to expand and…
Blenrep approved by US FDA for use in treatment of relapsed/refractory multiple myeloma
On Oct. 23, 2025, GSK announced the US Food and Drug Administration (FDA) has approved Blenrep (belantamab mafodotin-blmf)…
GRAIL PATHFINDER 2 Results Show Galleri ® Multi-Cancer Early Detection Blood Test Increased Cancer Detection
On Oct. 18, 2025, GRAIL announced that positive performance and safety results from its registrational PATHFINDER 2 study…
China’s Hansoh signs up to $1.45 billion deal for colorectal cancer drug with Roche
On Oct. 17, 2025, Chinese biotech Hansoh Pharma said it had signed a license agreement worth up to…
New lab-grown human embryo model produces blood cells
On Oct. 13, 2025, University of Cambridge scientists announced they have used human stem cells to create three-dimensional…
Biotechnology | Disease | Genomics | Oncology
Revolutionary blood test for ME / Chronic Fatigue unveiled
On Oct. 8, 2025, scientists at the University of East Anglia and Oxford Biodynamics announced they have developed a…
St. Jude calculators crunch the numbers to empower survivors of childhood cancer
On Oct. 7, 2025, St. Jude announced that it hosts multiple freely accessible Medical Risk Calculators on the…
the 2025 Nobel Prize in Physiology or Medicine awarded to Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi “for their discoveries concerning peripheral immune tolerance.”
On Oct. 6, 2026, The Nobel Assembly has awarded the 2025 Nobel Prize in Physiology or Medicine to Mary E….
Eli Lilly to invest over $1 billion in India to expand manufacturing capacity
On Oct. 5, 2025, Eli Lilly ill invest more than $1 billion in India in the coming years…
Mailed HPV test kits are cost-effective for screening
On Oct. 1, 2025, Kaiser Permanente Washington announced results of the first study within a U.S.-based health system…
Final Landmark Clinical Trial Data Demonstrates Deep, Durable Responses to Menin Inhibition in Acute Leukemia Patients
On Sept. 25, 2025, Final data from a landmark clinical trial in patients with an aggressive form of…
Melinda French Gates launches $100 million push for women’s health research
On Sept. 10, 2025, philanthropist Melinda French Gates announces she will invest $50 million in a women’s health…
Exact Sciences Launches Cancerguard™, First-of-Its-Kind Multi-Cancer Early Detection Blood Test
On Sept. 10, 2025, Exact Sciences announced the launch of the Cancerguard™ test, a new multi-cancer early detection…
Study Led by Roswell Park Finds GLP-1 Receptor Agonists Improve Lung Cancer Outcomes
On Sept. 8, 2025, research led by Sai Yendamuri, MD, MBA, FACS, Chair of Thoracic Surgery at Roswell…
Golden Goose Award Honors Federally Funded Breakthroughs in Cancer Treatments and Disease Diagnostics
On Sept. 3, 2025, The Golden Goose Award, which spotlights obscure, silly sounding or odd fundamental discovery research that…
Biotechnology | Diagnostics | Disease | Neurology | Oncology
New genetic biomarker flags aggressive brain tumors
On Sept. 1, 2025, a multi-institutional study suggests that typically classifiication of meningiomas by appearances may be deceiving…
Artificial Intelligence | Biotechnology | Diagnostics | Non-Profit Research | Oncology | Therapeutics
CPRIT Approves $27 Million In Grants for Cancer Research in Texas
On Aug. 20, 2025, The Cancer Prevention and Research Institute of Texas (CPRIT) announced the approval of 15…
New Method Advances Reliability of Ai with Applications in Medical Diagnostics
On Aug. 20, 2025, two studies led by Johns Hopkins Kimmel Cancer Center, Ludwig Center, and Johns Hopkins Whiting School of…
OHSU Knight Cancer Institute receives record $2 billion commitment from Phil and Penny Knight
On Aug. 14, 2025, Phil and Penny Knight announced a record-breaking $2 billion gift to the Oregon Health…
Bayer and Kumquat Biosciences enter global $1.3 Billion license and collaboration in precision oncology
On Aug. 12, 2025, Bayer and Kumquat Biosciences, a clinical-stage biotech company founded by pioneers of the KRAS…
Mayo Clinic treats first person in the US with a novel radiopharmaceutical therapy for breast cancer
On Aug. 1, 2025, the Mayo Clinic announced it had treated the first person in the U.S. using…
Study reveals a novel immune-based therapy that may be effective in hard-to-treat lung cancers
On Jul. 24, 2025, a team of researchers from TGen, part of City of Hope, and Baylor Scott…
Researchers design cancer vaccine blueprint for melanoma
On Jul. 24, 2025, University of Alberta (UA) researchers announced they have harnessed the power of artificial intelligence…